Cocrystal Pharma, Inc.
COCP
|
$1.562
-1.39%
3.9K
|
Health Technology
(0.0% 1d) (4.0% 1m) (-38.1% 1y) (0.0% 2d) (2.6% 3d) (4.0% 7d) (-92.37% volume)
Earnings Calendar: 2024-03-27
Market Cap: $ 15,891,460
http://www.cocrystalpharma.com
Sec Filling | Patents | 11 employees
(US) Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded on January 2, 2014 and is headquartered in Bothell, WA.
antiviral influenza hepatitis norovirus drug discovery injection
add to watch list Paper trade email alert is off
Press-releases
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
COCP | $1.562 -1.39% 3.9K
|
Health Technology
|
| O: 2.68%
H: 13.73%
C: -8.5%
pharma antiviral financial results
Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A
Published: 2024-03-19 (Crawled : 12:00) - globenewswire.com
COCP | $1.562 -1.39% 3.9K
|
Health Technology
|
| O: 1.35%
H: 0.0%
C: -5.33%
cc-4234 fda pharma influenza cc-42344
Cocrystal Pharma Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investigational Candidates
Published: 2024-01-04 (Crawled : 13:00) - globenewswire.com
COCP | $1.562 -1.39% 3.9K
|
Health Technology
|
| O: 0.56%
H: 2.78%
C: -0.56%
pharma antiviral update
Cocrystal Pharma Announces First-Patient-In for Phase 2a Human Challenge Study Evaluating Oral CC-42344 in Pandemic and Seasonal Influenza A
Published: 2023-12-06 (Crawled : 13:00) - globenewswire.com
COCP | $1.562 -1.39% 3.9K
|
Health Technology
|
| O: -0.3%
H: 4.76%
C: 0.3%
cc-4234 pharma influenza study cc-42344
Cocrystal Pharma Highlights its Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast
Published: 2023-11-29 (Crawled : 13:00) - globenewswire.com
COCP | $1.562 -1.39% 3.9K
|
Health Technology
|
| O: -2.17%
H: 5.56%
C: 2.78%
cc-4234 pharma west antiviral vaccine congress world influenza cc-42344
Cocrystal Pharma to Present at the NobleCon 19 Conference on December 4, 2023
Published: 2023-11-27 (Crawled : 13:00) - globenewswire.com
COCP | $1.562 -1.39% 3.9K
|
Health Technology
|
| O: 10.96%
H: 11.11%
C: 5.56%
pharma conference
Cocrystal Pharma Reports Third Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
Published: 2023-11-13 (Crawled : 13:00) - globenewswire.com
COCP | $1.562 -1.39% 3.9K
|
Health Technology
|
| O: -4.74%
H: 4.97%
C: 3.87%
pharma drug antiviral financial results
Cocrystal Pharma to Discuss Progress with Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast
Published: 2023-11-09 (Crawled : 13:00) - globenewswire.com
COCP | $1.562 -1.39% 3.9K
|
Health Technology
|
| O: 0.0%
H: 4.05%
C: 4.05%
cc-4234 pharma west antiviral vaccine congress world influenza cc-42344
Cocrystal Pharma Receives UK MHRA Authorization to Initiate Its Phase 2a Influenza Human Challenge Trial with Oral PB2 Inhibitor CC-42344
Published: 2023-10-31 (Crawled : 12:00) - globenewswire.com
COCP | $1.562 -1.39% 3.9K
|
Health Technology
|
| O: -1.52%
H: 10.15%
C: 6.87%
cc-4234 pharma authorization influenza trial cc-42344
Cocrystal Pharma Doses First Subjects in Clinical Study of CDI-988 For Pandemic Norovirus and Coronavirus
Published: 2023-09-28 (Crawled : 12:00) - globenewswire.com
COCP | $1.562 -1.39% 3.9K
|
Health Technology
|
| O: 0.0%
H: 6.12%
C: -0.51%
cdi-988 pharma norovirus study
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Last 48 Hours Insiders Buying
RKT P 347 | $12.55 -0.63% 0.48% 1.7M
|
Finance
|
22:30
NWFL | News | $24.6 2.03% 1.99% 9.9K
|
Finance
|
22:00
TGEN P 10000 | $0.685 39.71% 6.6K
|
Utilities
|
20:01
MNSB P 310 | $15.88 -2.93% -3.02% 46K
|
Finance
|
15:30
RMCF | $3.54 0.28% 7.1K
|
Consumer Non-Durables
|
20:10